v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN CONTINGENTLY REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ (DEFICIT) EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2020 504,000,000        
Beginning balance at Dec. 31, 2020 $ 5,244,000,000        
Contingently Redeemable Convertible Preferred Stock          
Capital stock issuance (in shares) 72,000,000        
Capital stock issuance $ 2,650,000,000        
Ending balance (in shares) at Mar. 31, 2021 576,000,000        
Ending balance at Mar. 31, 2021 $ 7,894,000,000        
Beginning balance (in shares) at Dec. 31, 2020   101,000,000      
Beginning balance at Dec. 31, 2020 (1,384,000,000) $ 0 $ 302,000,000 $ (1,686,000,000) $ 0
Stockholders' (Deficit) Equity          
Capital stock issuance 1,000,000   1,000,000    
Net loss (414,000,000)     (414,000,000)  
Ending balance (in shares) at Mar. 31, 2021   101,000,000      
Ending balance at Mar. 31, 2021 $ (1,797,000,000) $ 0 303,000,000 (2,100,000,000) 0
Beginning balance (in shares) at Dec. 31, 2020 504,000,000        
Beginning balance at Dec. 31, 2020 $ 5,244,000,000        
Ending balance (in shares) at Sep. 30, 2021 576,000,000        
Ending balance at Sep. 30, 2021 $ 7,894,000,000        
Beginning balance (in shares) at Dec. 31, 2020   101,000,000      
Beginning balance at Dec. 31, 2020 (1,384,000,000) $ 0 302,000,000 (1,686,000,000) 0
Stockholders' (Deficit) Equity          
Other comprehensive loss 0        
Net loss (2,227,000,000)        
Ending balance (in shares) at Sep. 30, 2021   102,000,000      
Ending balance at Sep. 30, 2021 $ (3,607,000,000) $ 0 306,000,000 (3,913,000,000) 0
Beginning balance (in shares) at Mar. 31, 2021 576,000,000        
Beginning balance at Mar. 31, 2021 $ 7,894,000,000        
Ending balance (in shares) at Jun. 30, 2021 576,000,000        
Ending balance at Jun. 30, 2021 $ 7,894,000,000        
Beginning balance (in shares) at Mar. 31, 2021   101,000,000      
Beginning balance at Mar. 31, 2021 (1,797,000,000) $ 0 303,000,000 (2,100,000,000) 0
Stockholders' (Deficit) Equity          
Capital stock issuance 2,000,000   2,000,000    
Net loss (580,000,000)     (580,000,000)  
Ending balance (in shares) at Jun. 30, 2021   101,000,000      
Ending balance at Jun. 30, 2021 $ (2,375,000,000) $ 0 305,000,000 (2,680,000,000) 0
Ending balance (in shares) at Sep. 30, 2021 576,000,000        
Ending balance at Sep. 30, 2021 $ 7,894,000,000        
Stockholders' (Deficit) Equity          
Capital stock issuance (in shares)   1,000,000      
Capital stock issuance 1,000,000   1,000,000    
Other comprehensive loss 0        
Net loss (1,233,000,000)     (1,233,000,000)  
Ending balance (in shares) at Sep. 30, 2021   102,000,000      
Ending balance at Sep. 30, 2021 $ (3,607,000,000) $ 0 306,000,000 (3,913,000,000) 0
Beginning balance (in shares) at Dec. 31, 2021 0        
Beginning balance at Dec. 31, 2021 $ 0        
Ending balance (in shares) at Mar. 31, 2022 0        
Ending balance at Mar. 31, 2022 $ 0        
Beginning balance (in shares) at Dec. 31, 2021 900,000,000 900,000,000      
Beginning balance at Dec. 31, 2021 $ 19,514,000,000 $ 1,000,000 25,887,000,000 (6,374,000,000) 0
Stockholders' (Deficit) Equity          
Capital stock issuance (in shares)   1,000,000      
Capital stock issuance 1,000,000   1,000,000    
Stock-based compensation 338,000,000   338,000,000    
Net loss (1,593,000,000)     (1,593,000,000)  
Ending balance (in shares) at Mar. 31, 2022   901,000,000      
Ending balance at Mar. 31, 2022 $ 18,260,000,000 $ 1,000,000 26,226,000,000 (7,967,000,000) 0
Beginning balance (in shares) at Dec. 31, 2021 0        
Beginning balance at Dec. 31, 2021 $ 0        
Ending balance (in shares) at Sep. 30, 2022 0        
Ending balance at Sep. 30, 2022 $ 0        
Beginning balance (in shares) at Dec. 31, 2021 900,000,000 900,000,000      
Beginning balance at Dec. 31, 2021 $ 19,514,000,000 $ 1,000,000 25,887,000,000 (6,374,000,000) 0
Stockholders' (Deficit) Equity          
Other comprehensive loss (4,000,000)        
Net loss $ (5,029,000,000)        
Ending balance (in shares) at Sep. 30, 2022 921,000,000 921,000,000      
Ending balance at Sep. 30, 2022 $ 15,337,000,000 $ 1,000,000 26,743,000,000 (11,403,000,000) (4,000,000)
Beginning balance (in shares) at Mar. 31, 2022 0        
Beginning balance at Mar. 31, 2022 $ 0        
Ending balance (in shares) at Jun. 30, 2022 0        
Ending balance at Jun. 30, 2022 $ 0        
Beginning balance (in shares) at Mar. 31, 2022   901,000,000      
Beginning balance at Mar. 31, 2022 18,260,000,000 $ 1,000,000 26,226,000,000 (7,967,000,000) 0
Stockholders' (Deficit) Equity          
Capital stock issuance (in shares)   15,000,000      
Capital stock issuance 57,000,000   57,000,000    
Stock-based compensation 264,000,000   264,000,000    
Other comprehensive loss (1,000,000)       (1,000,000)
Net loss (1,712,000,000)     (1,712,000,000)  
Ending balance (in shares) at Jun. 30, 2022   916,000,000      
Ending balance at Jun. 30, 2022 $ 16,868,000,000 $ 1,000,000 26,547,000,000 (9,679,000,000) (1,000,000)
Ending balance (in shares) at Sep. 30, 2022 0        
Ending balance at Sep. 30, 2022 $ 0        
Stockholders' (Deficit) Equity          
Capital stock issuance (in shares)   5,000,000      
Capital stock issuance 7,000,000   7,000,000    
Stock-based compensation 189,000,000   189,000,000    
Other comprehensive loss (3,000,000)       (3,000,000)
Net loss $ (1,724,000,000)     (1,724,000,000)  
Ending balance (in shares) at Sep. 30, 2022 921,000,000 921,000,000      
Ending balance at Sep. 30, 2022 $ 15,337,000,000 $ 1,000,000 $ 26,743,000,000 $ (11,403,000,000) $ (4,000,000)